Pub. Date : 2021 Jan
PMID : 33060857
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Currently, the field faces an unprecedented number of combinations of activating mutations with distinct resistance mutations in parallel to the approval of osimertinib as a first-line drug for EGFR-mutant lung cancer. | osimertinib | epidermal growth factor receptor | Homo sapiens |